Office Hysteroscopy in Secondary Infertility After Cesarean Section
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03166657|
Recruitment Status : Not yet recruiting
First Posted : May 25, 2017
Last Update Posted : May 25, 2017
All women with history of secondary infertility after caesarean section will be subjected to office hysteroscopy according to Royal college of obstetrics and gynecology guidelines to diagnose any subtle uterine abnormalities not detected by conventional means.
Hysteroscopic examination will be done during the proliferation phase of the menstrual cycle.
The hysteroscopic evaluation will include assessment of the cervical canal, intrauterine lesions, the endometrium and the uterotubal junction. .
If hysteroscopy reveal a lesion, its type, size, location will be recorded. Transvaginal ultrasound will be done after the procedure to detect fluid in the douglas pouch to confirm patent tubes.
Asses the uterine scar in details.
|Condition or disease||Intervention/treatment|
|Infertility, Female||Procedure: office hysteroscopy|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Role of Office Hysteroscopy in Cases of Secondary Infertility After Cesarean Section|
|Estimated Study Start Date :||July 1, 2017|
|Estimated Primary Completion Date :||January 1, 2019|
|Estimated Study Completion Date :||March 1, 2019|
- Procedure: office hysteroscopy
A speculum is first inserted into the vagina. The hysteroscope is then inserted and gently moved through the cervix into uterus. Carbon dioxide gas or a fluid, such as saline will be put through the hysteroscope into uterus to expand it. The gas or fluid helps see the lining more clearly. The amount of fluid used is carefully checked throughout the procedure
- percentage of patients with abnormal scar findings in hysteroscopy [ Time Frame: 1 year ]color of the scar and presence of niche
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03166657
|Contact: hazem saad eldin, firstname.lastname@example.org|
|Contact: ahmed abdelalim, email@example.com|